REVIEW PAPER - Challenges and Opportunities in Lassa fever Control Efforts in Nigeria

Anise N. Happi, Chinedu A. Ugwu, Kazeem Akano, Christian T. Happi


Lassa fever is a viral zoonotic tropical disease endemic in parts of West Africa. It causes substantial mortality, morbidity and economic burdens on affected populations. The year 2019 marked the 50th anniversary of the first diagnosis of Lassa fever in Nigeria. Over the years, a few and sporadic intervention measures have been undertaken to control Lassa fever in Nigeria. However, the disease has remained a burden due to neglect, and apathy from the Government. Here we highlight the Lassa fever control efforts so far undertaken in Nigeria. We also point to some challenges and opportunities for effective Lassa fever control efforts. In addition, we proposed few Lassa fever control measures, which vary from advocacies, training of local communities and health workers in the use of rapid, cheap diagnostic tools. We also propose an integrated genomic surveillance platform that utilizes one health approach, in tracking and tackling Lassa fever, as the key future of Lassa fever control effort. In this review, we present IGOHRAL, an integrated genomic platform that utilizes clinical, genomic and epidemiological data in a one-health approach to tackle Lassa fever problem.

Lassa fever (LF) is a serious viral hemorrhagic fever endemic in West Africa. The history of Lassa fever virus (LVS) in Nigeria is that of neglect, wickedness and apathy (Akpede et al., 2018). Lassa virus was first diagnosed in a missionary hospital in Nigeria in 1969 (Carey et al., 1972).  There was an outbreak of a febrile illness involving hospital staff and those who visited the hospitals. The aetiology was later confirmed to be LVS. Prior to this outbreak, there have been several descriptions of illness resembling LF (Monath, 1975).  However, a genomics study by Anderson et al. later confirmed that the LVS emerged in present day Nigeria over 1060 years ago (Andersen et al., 2015).


Challenges, Opportunity, Lassa fever, Nigeria

Full Text:



Ajayi NA, Nwigwe CG, Azuogu BN, Onyire BN, Nwonwu EU, Ogbonnaya LU, Onwe FI, Ekaete T, Güther S, & Ukwaja KN (2013). Containing a Lassa fever epidemic in a resource-limited setting : outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012). International Journal of Infectious Diseases. 17: e1011-e1016.

Ajogbasile FV, Oguzie JU, Oluniyi PE, Eromon P, Uwanibe J, Mehta SB, Siddle KJI Odia I, Winnicki SM, Akpede N, Akpede G, Okogbenin S, MacInnis BL, Folarin OA, Schaffner SF, Ogbaini-Emovon E, Tomori OI, Ihekweazu C, Sabeti PC, Happi CT (2019). Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria.

Akpede GO, Asogun DA, Okogbenin SA, & Okokhere PO (2018). Lassa fever outbreaks in Nigeria Lassa fever outbreaks in Nigeria. Expert Review of Anti-Infective Therapy, 16, 663–666.

Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, Moses LM, Folarin OA, Goba A, Odia I, Ehiane PE, Momoh M, England EM, Winnicki S, Branco LM, Gire S K, Phelan E, Tariyal R, Tewhey R, Omoniwa O, Fullah M, Fonnie R, Fonnie M, Kanneh L, Jalloh S, Gbakie M, Saffa S, Karbo K, Gladden AD, Qu J, Stremlau M, Nekoui M, Finucane HK, Tabrizi S, Vitti JJ, Birren B, Fitzgerald M, McCowan C, Ireland A, Berlin AM, Bochicchio J, Tazon-Vega B, Lennon NJ, Ryan EM, Bjornson Z, Milner DA (Jr), Lukens AK, Broodie N, Rowland M, Heinrich M, Akdag M, Schieffelin JS, Levy D, Akpan H, Bausch DG, Rubins K, McCormick JB, Lander ES, Günther S, Hensley L, Okogbenin S, Viral Hemorrhagic Fever Consortium, Schaffner SF, Okokhere PO, Khan SH, Grant DS, Akpede GO, Asogun DA, Gnirke A, Levin JZ, Happi CT, Garry RF, & Sabeti PC (2015). Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell, 162, 738–750.

Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, Fullah M, Nelson DKS, Bush DJ, Rowland MM, Heinrich ML, Koval AP, Cross RW, Barnes KG, Lachenauer AE, Lin AE, Nekoui M, Kotliar D, Winnicki SM, Siddle KJ, Gbakie M, Fonnie M, Koroma VJ, Kanneh L, Kulakosky PC, Hastie KM, Wilson RB, Andersen KG, Folarin OO, Happi CT, Sabeti PC, Geisbert TW, Saphire EO, Khan SH, Grant DS, Schieffelin JS , Branco LM & Garry RF (2018). Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Scientific Reports, 8, 8:5939 doi: 10.1038/s41598-018-24246-w

Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom ALMD, Stroh G, Casals J, & Henderson BE (1972). Lassa fever epidemiological aspects of the 1970 epidemic, Jos, Nigeria, Transactions of the Royal Sociaty of Tropical Medicine and Hygiene 66: 402–408. doi: 10.1016/0035-9203(72)90271-4

Centers for Disease Control and Prevention, CDC, World Health Organisation, W. (2010). Technical guidelines for integrated disease surveillance and response in the African region.

Ehichioya DU, Asogun DA, Ehimuan J, Okokhere PO, Pahlmann M, Ölschläger S, Becker-Ziaja B, Günther S & Omilabu SA (2012) Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005–2008 Tropical Medicine and International Health 17, 1001-1004.

Folarin OA, Happi AN, & Happi CT (2014). Empowering African genomics for infectious disease control, Genome Biology 15: 515. Doi: 10.1186/s13059-014-0515-y

Gere SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC (2014). Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science, 345, 1369–1372. Doi: 10.1126/science.1259657.

Gratz NG & Arata AA (1975). Problems associated with the control of rodents in tropical Africa, Bulletin of the World Health Organization 52: 697–706.

Gröne O & Garcia-Barbero M. (2001). Integrated care: A position paper of the WHO European office for integrated health care services. International Journal of Integrated Care 1: e21. doi: 10.4304/jsw.7.7.1524-1530

Hallam HJ, Hallam S, Rodriguez SE, Barrett ADT, Beasley DWC, Chua A, Ksiazek T G, Milligan GN, Sathiyamoorthy V & Reece LM (2018). Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. npj Vaccines, 3: 11. doi: 10.1038/s41541-018-0049-5

Happi AN, Ugwu CA, & Happi CT (2019). Preparing for the next Ebola outbreak: in-country genomic capacity in Africa. Lancet Infectious Diseases 19 : 569–570.

Ladner JT, Grubaugh ND, Pybus OG, & Andersen KG (2019). Precision epidemiology for infectious disease control. Nature Medicine, 25: 206–211. doi: 10.1038/s41591-019-0345-2

Mariën J, Borremans B, Kourouma F, Baforday J, Günther S, Magassouba N, Leirs H & Fichet-Calvet E (2019). Evaluation of rodent control to fight Lassa fever based on field data and mathematical modelling. Emerging Microbes and Infection 8: 640-649. doi: 10.1080/22221751.2019.1605846

Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A. (1974). Lassa virus isolation from Mastomys natalensis rodents during an Epidemic in Sierra Leone. Science 185: 263 - 265.

Monath TP (1975). Lassa fever : review of epidemiology and epizootiology. Bulletin of the World Health Organization 52: 577–592.

Nigeria Centre for Disease Control (2013). Technical Guidelines for Integrated Disease Surveillance and Response in Nigeria. NCDC, Abuja, Nigeria.

Nigeria Centre for Disease Control. (2017). Viral Haemorrhagic Fevers Preparedness and Response Plan, (June). Retrieved from

NCDC, N. C. F. D. C. (2018). NCDC 2017-2021 Strategic Plan.




Nigeria Centre for Disease Control,. (2018). ANNUAL REPORT 2018.

Nigeria Centre for Disease Control,. (2018). National Guidelines for Lassa Fever Case Management.

Ogbu O, Ajuluchukwu E, Uneke CJ (2007) Lassa fever in West African sub-region: An overview. Journal of Vector Borne Diseases 44:1-11

Olayemi A, Cadar D, Magassouba, N, Obadare A, Kourouma F, Oyeyiola A, Fasogbon S, Igbokwe J, Rieger T, Bockholt S, Jérôme H, Schmidt-Chanasit J, Garigliany M, Lorenzen S, Igbahenah F, Fichet JN, Ortsega D, Omilabu S, Günther S & Fichet-Calvet E. (2016). New Hosts of The Lassa Virus. Scientific Reports, 6: 25280. doi: 10.1038/srep25280.

Richmond JK & Baglole DJ (2003). Lassa fever: epidemiology, clinical features, and social consequences, British Medical Journal 327: 1271–1275. Doi: 10.1136/bmj.327.7426.1271

Siddle KJ, Eromon P, Barnes KG, Mehta S, Oguzie JU, Odia I, Schaffner SF, Winnicki SM, Shah RR, Qu J, Wohl S, Brehio P, Iruolagbe C, Aiyepada J, Uyigue E, Akhilomen P, Okonofua G, Ye S, Kayode T, Ajogbasile F, Uwanibe J, Gaye A, Momoh M, Chak B, Kotliar D, Carter A, Gladden-Young A, Freije CA, Omoregie O, Osiemi B, Muoebonam EB, Airende M, Enigbe R, Ebo B, Nosamiefan I, Oluniyi P, Nekoui M, Ogbaini-Emovon E, Garry RF, Andersen KG, Park DJ, Yozwiak NL, Akpede G, Ihekweazu C, Tomori O, Okogbenin S, Folarin OA, Okokhere PO, MacInnis BL, Sabeti PC & Happi CT (2018). Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018. New England Journal of Medicine 379: 1745-1753. Doi: 10.1056/NEJMoa1804498.

Tambo E, Adetunde OT, & Olalubi OA (2018). Re-emerging Lassa fever outbreaks in Nigeria : Re-enforcing “ One Health ” community surveillance and emergency response practice. Infectious Diseases of Poverty 7: 37. Doi: 10.1186/s40249-018-0421-8

Wulff H, Fabiyi A, & Monath TP (1975). Recent isolations of Lassa virus from Nigerian rodents Bulletin of the Worltd Health Organization 52: 609–613.

World Health Organization (2019) Emergencies preparedness and response: Disease outbreak news on Lassa fever – Nigeria. Accessed on 13 February 2020


  • There are currently no refbacks.